Search for Clinical Trial Results

Sponsored By

Neurofibroma - 63 Studies Found

Status Study
Recruiting Study Name: Photodynamic Therapy for Benign Dermal Neurofibromas
Condition: NEUROFIBROMATOSIS 1
Date: 2016-03-25
Interventions: Procedure: PDT Treatment Drug: Levulan Kerastick
Completed Study Name: Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1
Condition: Neurofibromatosis
Date: 2008-09-16
Interventions: Drug: Pirfenidone Capsule 800 mg TID, oral
Active, not recruiting Study Name: Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
Condition: Neurofibromatoses
Date: 2012-09-05
Interventions:
  • Drug: Levulan (5-aminolevulinic acid) uptake.

Completed Study Name: A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Date: 2008-02-20
Interventions: Drug: Sirolimus This phase II study will evaluate children and adults with neurofibromatosis type-1 (NF1
Active, not recruiting Study Name: Medical Treatment of "High-Risk" Neurofibromas
Condition: Neurofibromatosis 1
Date: 2009-01-16
Interventions:
  • Drug: Peg-Interferon alpha-2b

Active, not recruiting Study Name: How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Condition: Neurofibromatosis Type 1
Date: 2012-06-21
Completed Study Name: Quality of Friendships in Children With Neurofibromatosis
Condition: Neurofibromatosis
Date: 2007-07-26
Interventions: Behavioral: Questionnaire Questionnaire about the patient's relationship with their best friend.
Completed Study Name: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas
Condition:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Date: 2011-08-08
    Interventions: Drug: RAD001: Everolimus 10 mg of RAD001 will be self-administered orally once daily continuously for on
Completed Study Name: Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
Condition:
  • Plexiform Neurofibromas
  • NF1

Date: 2000-11-03
Recruiting Study Name: PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
Condition:
  • Neurofibroma, Plexiform
  • Precursor Cell Lymphoblastic Leukemia-L
    Date: 2015-03-17
    Interventions: Drug: PLX3397 Take oral drug daily for a 28 day cycle
Next >>>